145 related articles for article (PubMed ID: 36054789)
1. Prevalence of alcohol consumption in emergency presentations: Novel approach using two biomarkers, ethanol and phosphatidylethanol.
Cameron CM; Vuong K; McWhinney B; Zournazi A; Manzanero S; Warren J; Mitchell G; McCreanor V; Vallmuur K; Howell T; Ungerer JPJ
Drug Alcohol Rev; 2023 Jan; 42(1):146-156. PubMed ID: 36054789
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Alcohol Consumption in Emergency department presentations (PACE) in Queensland, Australia, using alcohol biomarkers ethanol and phosphatidylethanol: an observational study protocol.
Vuong KA; Manzanero S; Ungerer JPJ; Mitchell G; McWhinney B; Vallmuur K; Warren J; McCreanor V; Howell T; Pollard C; Schuetz M; Zournazi A; Cameron CM
BMJ Open; 2021 Nov; 11(11):e047887. PubMed ID: 34753753
[TBL] [Abstract][Full Text] [Related]
3. Factors associated with higher alcohol concentrations in emergency department presentations: PACE study.
Cameron CM; Vuong K; McWhinney B; Zournazi A; Manzanero S; Warren J; Mitchell G; Vallmuur K; Howell T; Ungerer JPJ
Drug Alcohol Rev; 2023 Nov; 42(7):1796-1806. PubMed ID: 37703216
[TBL] [Abstract][Full Text] [Related]
4. Phosphatidylethanol, ethyl glucuronide and ethanol in blood as complementary biomarkers for alcohol consumption.
Neumann J; Beck O; Böttcher M
J Mass Spectrom Adv Clin Lab; 2021 Nov; 22():3-7. PubMed ID: 34939049
[TBL] [Abstract][Full Text] [Related]
5. Identification of unhealthy alcohol use by self-report and phosphatidylethanol (PEth) blood concentrations in an acute psychiatric department.
Finanger T; Vaaler AE; Spigset O; Aamo TO; Andreassen TN; Gråwe RW; Skråstad RB
BMC Psychiatry; 2022 Apr; 22(1):286. PubMed ID: 35449039
[TBL] [Abstract][Full Text] [Related]
6. An automated sample preparation approach for routine liquid chromatography tandem-mass spectrometry measurement of the alcohol biomarkers phosphatidylethanol 16:0/18:1, 16:0/16:0 and 18:1/18:1.
Casati S; Ravelli A; Angeli I; Durello R; Minoli M; Orioli M
J Chromatogr A; 2019 Mar; 1589():1-9. PubMed ID: 30598290
[TBL] [Abstract][Full Text] [Related]
7. PEth 16:0/18:1 and 16:0/18:2 after consumption of low doses of alcohol-A contribution to cutoff discussion.
Aboutara N; Jungen H; Szewczyk A; Müller A; Iwersen-Bergmann S
Drug Test Anal; 2023 Jan; 15(1):104-114. PubMed ID: 36181234
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the Pharmacokinetics of Phosphatidylethanol 16:0/18:1 and 16:0/18:2 in Human Whole Blood After Alcohol Consumption in a Clinical Laboratory Study.
Javors MA; Hill-Kapturczak N; Roache JD; Karns-Wright TE; Dougherty DM
Alcohol Clin Exp Res; 2016 Jun; 40(6):1228-34. PubMed ID: 27130527
[TBL] [Abstract][Full Text] [Related]
9. Set-up of a population-based model to verify alcohol abstinence via monitoring of the direct alcohol marker phosphatidylethanol 16:0/18:1.
Van Uytfanghe K; Heughebaert L; Abatih E; Stove CP
Addiction; 2022 Jul; 117(7):2108-2118. PubMed ID: 35072319
[TBL] [Abstract][Full Text] [Related]
10. High prevalence of unhealthy alcohol use and comparison of self-reported alcohol consumption to phosphatidylethanol among women engaged in sex work and their male clients in Cambodia.
Couture MC; Page K; Sansothy N; Stein E; Vun MC; Hahn JA
Drug Alcohol Depend; 2016 Aug; 165():29-37. PubMed ID: 27251102
[TBL] [Abstract][Full Text] [Related]
11. Determination of phosphatidyl ethanol (PEth) 16:0/18:1 in dried blood samples of drivers involved in traffic accidents: A pilot study.
Daglioglu N; Efeoglu Ozseker P; Dengiz H; Kekec Z
Leg Med (Tokyo); 2022 Sep; 58():102091. PubMed ID: 35623236
[TBL] [Abstract][Full Text] [Related]
12. [Determination of phosphatidylethanol in whole-blood by liquid chromatography-tandem mass spectrometry based on intelligent scheduled time-zone acquisition technology and the application to population level survey].
Liu Z; Dong J; Li H; Yang R; Shao Z; Wang S
Se Pu; 2023 Feb; 41(2):131-141. PubMed ID: 36725709
[TBL] [Abstract][Full Text] [Related]
13. Determination of the formation rate of phosphatidylethanol by phospholipase D (PLD) in blood and test of two selective PLD inhibitors.
Schröck A; Henzi A; Bütikofer P; König S; Weinmann W
Alcohol; 2018 Dec; 73():1-7. PubMed ID: 30103144
[TBL] [Abstract][Full Text] [Related]
14. Performance of PEth Compared With Other Alcohol Biomarkers in Subjects Presenting For Occupational and Pre-Employment Medical Examination.
Neumann J; Beck O; Helander A; Böttcher M
Alcohol Alcohol; 2020 Jun; 55(4):401-408. PubMed ID: 32363383
[TBL] [Abstract][Full Text] [Related]
15. Phosphatidylethanol as Blood Biomarker of Alcohol Consumption in Early Pregnancy: An Observational Study in 4,067 Pregnant Women.
Finanger T; Spigset O; Gråwe RW; Andreassen TN; Løkken TN; Aamo TO; Bratt GE; Tømmervik K; Langaas VS; Finserås K; Salvesen KÅB; Skråstad RB
Alcohol Clin Exp Res; 2021 Apr; 45(4):886-892. PubMed ID: 33586791
[TBL] [Abstract][Full Text] [Related]
16. Investigating the use of PEth, CDT and MCV to evaluate alcohol consumption in a cohort of homeless individuals- A comparison of different alcohol biomarkers.
Aboutara N; Müller A; Jungen H; Szewczyk A; van Rüth V; Bertram F; Püschel K; Heinrich F; Iwersen-Bergmann S
Forensic Sci Int; 2022 Feb; 331():111147. PubMed ID: 34920332
[TBL] [Abstract][Full Text] [Related]
17. Improved detection of alcohol consumption using the novel marker phosphatidylethanol in the transplant setting: results of a prospective study.
Andresen-Streichert H; Beres Y; Weinmann W; Schröck A; Müller A; Skopp G; Pischke S; Vettorazzi E; Lohse A; Nashan B; Sterneck M
Transpl Int; 2017 Jun; 30(6):611-620. PubMed ID: 28295675
[TBL] [Abstract][Full Text] [Related]
18. Phosphatidylethanol confirmed alcohol use among ART-naïve HIV-infected persons who denied consumption in rural Uganda.
Muyindike WR; Lloyd-Travaglini C; Fatch R; Emenyonu NI; Adong J; Ngabirano C; Cheng DM; Winter MR; Samet JH; Hahn JA
AIDS Care; 2017 Nov; 29(11):1442-1447. PubMed ID: 28278568
[TBL] [Abstract][Full Text] [Related]
19. Assessing phosphatidylethanol (PEth) levels reflecting different drinking habits in comparison to the alcohol use disorders identification test - C (AUDIT-C).
Schröck A; Wurst FM; Thon N; Weinmann W
Drug Alcohol Depend; 2017 Sep; 178():80-86. PubMed ID: 28645063
[TBL] [Abstract][Full Text] [Related]
20. Preliminary evaluation of phosphatidylethanol and alcohol consumption in patients with liver disease and hypertension.
Stewart SH; Reuben A; Brzezinski WA; Koch DG; Basile J; Randall PK; Miller PM
Alcohol Alcohol; 2009; 44(5):464-7. PubMed ID: 19535495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
